1. "Natural product" contains high levels of tadalafil

   News item 18 June 2022 Pages: 1 - 1

2. Febrile seizures in children following vaccination rare adverse events

   News item 18 June 2022 Pages: 2 - 2

3. Hypnomidate-related thrombophlebitis

   News item 18 June 2022 Pages: 3 - 3

4. Joint supplements recalled in USA due to unlisted diclofenac

   News item 18 June 2022 Pages: 4 - 4

5. AEs after BCG vaccination in Japanese infants

   Clinical study 18 June 2022 Pages: 5 - 5

6. AEs of phosphoinositide 3 kinase Inhibitors in patients with lymphoma

   Clinical study 18 June 2022 Pages: 6 - 6

7. Antibacterial-associated AKI in older patients

   Clinical study 18 June 2022 Pages: 7 - 7

8. Antipsychotics may increase risk of AKI in elderly

   Clinical study 18 June 2022 Pages: 8 - 8

9. Janssen COVID-19 vaccine increases risk of thrombocytopenia

   Clinical study 18 June 2022 Pages: 9 - 9

10. Risk of Guillain-Barre Syndrome after COVID-19 vaccination

    Clinical study 18 June 2022 Pages: 10 - 10

11. Risk of myocarditis or pericarditis after COVID-19 mRNA vaccines

    Clinical study 18 June 2022 Pages: 11 - 11

12. SAEs after BNT162b2, CoronaVac and ChAdOx1 vaccination

    Clinical study 18 June 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 18 June 2022 Pages: 13 - 13

14. Aciclovir/azathioprine/prednisone

    Case report 18 June 2022 Pages: 14 - 14

15. Aciclovir/foscarnet/immune-globulin

    Case report 18 June 2022 Pages: 15 - 15

16. Ad26.COV2-S

    Case report 18 June 2022 Pages: 16 - 16

17. Ad26.cov2-s/elasomeran

    Case report 18 June 2022 Pages: 17 - 17

18. Adalimumab

    Case report 18 June 2022 Pages: 18 - 18

19. Adalimumab/azathioprine

    Case report 18 June 2022 Pages: 19 - 19

20. Adenosine

    Case report 18 June 2022 Pages: 20 - 20

21. Adenosine/pheniramine

    Case report 18 June 2022 Pages: 21 - 21

22. Afatinib/bevacizumab/ramucirumab

    Case report 18 June 2022 Pages: 22 - 22

23. Allopurinol

    Case report 18 June 2022 Pages: 23 - 23

24. Alteplase/heparin

    Case report 18 June 2022 Pages: 24 - 24

25. Amikacin/ceftolozane/tazobactam/gentamicin

    Case report 18 June 2022 Pages: 25 - 25

26. Amikacin/isoniazid/pyrazinamide

    Case report 18 June 2022 Pages: 26 - 26

27. Amoxicillin

    Case report 18 June 2022 Pages: 27 - 27

28. Amphotericin-B

    Case report 18 June 2022 Pages: 28 - 28

29. Amphotericin-b-liposomal/voriconazole

    Case report 18 June 2022 Pages: 29 - 29

30. Ampicillin/sulbactam/cefmetazole

    Case report 18 June 2022 Pages: 30 - 30

31. Antibacterials/cetirizine/methylprednisolone

    Case report 18 June 2022 Pages: 31 - 31

32. Antibacterials/immunosuppressants

    Case report 18 June 2022 Pages: 32 - 32

33. Antibiotics/hydroxychloroquine

    Case report 18 June 2022 Pages: 33 - 33

34. Antiepileptic drugs/analgesics

    Case report 18 June 2022 Pages: 34 - 34

35. Antiepileptic-drugs/hydroxycarbamide/propofol

    Case report 18 June 2022 Pages: 35 - 35

36. Antifungals/antineoplastics/nitric-oxide

    Case report 18 June 2022 Pages: 36 - 36

37. Antiglaucomas

    Case report 18 June 2022 Pages: 37 - 37

38. Antineoplastic drugs

    Case report 18 June 2022 Pages: 38 - 38

39. Antineoplastics

    Case report 18 June 2022 Pages: 39 - 39

40. Antineoplastics

    Case report 18 June 2022 Pages: 40 - 40

41. Antineoplastics

    Case report 18 June 2022 Pages: 41 - 41

42. Antineoplastics

    Case report 18 June 2022 Pages: 42 - 42

43. Antineoplastics

    Case report 18 June 2022 Pages: 43 - 43

44. Antineoplastics

    Case report 18 June 2022 Pages: 44 - 44

45. Antineoplastics

    Case report 18 June 2022 Pages: 45 - 45

46. Antineoplastics

    Case report 18 June 2022 Pages: 46 - 46

47. Antineoplastics

    Case report 18 June 2022 Pages: 47 - 47

48. Antineoplastics

    Case report 18 June 2022 Pages: 48 - 48

49. Antineoplastics

    Case report 18 June 2022 Pages: 49 - 49

50. Antineoplastics

    Case report 18 June 2022 Pages: 50 - 50